WORLD NEWS SUPERFAST

India News – From India-Mumbai to every small town-town in India, there is a fierce fight with Remedesvir. Somewhere politics is heating up, and somewhere people are buying it by paying many times more money in black. The central government said on Monday that Remedesvir Corona is not a life-saving drug for patients, it is unnecessary and its use will not benefit, it is not guaranteed. Seeing all this, on Monday, the Bombay High Court summoned the reply from the Central Government.

The High Court questioned the Center on what basis these injections are being distributed to the states? When 40% of the corona patients in the country are in Maharashtra, Remedisvir should also be given in the same proportion. The High Court also reprimanded the Maharashtra government. The court said that the district is being distributed as arbitrary Remedisvir.

Governments surrounded by Ramdesivir: Bombay HC asks Center – why not 40% of cases in Maharashtra so many injections?

Earlier, the central government had banned the export of Remedicivir injection last week. Actually, this injection is being used in severe cases of corona. The doctors are also prescribing it indiscriminately and there is a lot of black marketing. At present, 7 companies in the country are making this drug, which has the capacity to make 39 lakh vials every month, ie 1.30 lakh doses daily. While the demand is constantly increasing.

What is Ramesdivir?

Remadecivir is an anti-viral drug, which reportedly stops the virus from growing. In 2009, Gilead Sciences of the US created it to treat Hepatitis C. Research was conducted on this till 2014 and then it was used in the treatment of Ebola. Remadecivir was then used in the treatment of Corona Virus Family’s Middle East Respiratory Syndrome (MERS or MERS) and Severe Acute Respiratory Syndrome (SARS or SARS).

This formula overcomes the enzyme required for the virus to thrive in the body. On 28 October 2020, the US regulator US-FDA approved Remedisivir for the treatment of Kovid-19. When Donald Trump was infected at that time, he was also given Remedisvir.

Is Remadecivir really effective?

Do not know. According to data from Gilead Sciences Remadecivir Kovid-19 reduces the recovery time to five days. So far, more than 50 countries are using it in the treatment of Kovid-19. However, the WHO has not confirmed this claim in the trials.

The WHO said that remadecivir has not shown any effect on the patient’s severe symptoms or life-threatening situations. Side effects have definitely been seen. These include increased levels of liver enzymes, allergic reaction, changes in blood pressure and heart rate, decreased levels of oxygen blood, fever, difficulty in breathing, swelling of lips, around eyes. Blood sugar is also shown to be enlarged.

The Indian government has also said that this injection is not included in lifesaving medicine

It is not even given at home. Yet last week, the Center fixed the price of Remedicivir injection at Rs 3500. It also said that production would double by the end of April. For this, 6 more companies have been approved to produce it.

Currently, 38.80 lakh injections are being produced every month in the country.

About 8 million injections will be ready by the end of this month. According to the ministry, there are a total of 7 manufacturers of Remadecivir injection in the country at the moment. Now 6 more companies have been approved to produce it. With this, 10 lakh injections will be made every month. In addition, 3 million more units are in the final stages of construction.

How many companies are making Remedisvir in India?

There are 7 pharmaceutical companies in India currently manufacturing Remedisivir. These include Hetero Drugs, Zydus Cadila, Sun Pharma and Cipla. He has a licensing agreement with Gilead. These companies have a total production capacity of 39 lakh vials every month. Zydus reduced the price of 100 mg vial from Rs 2,800 to Rs 899 in March.

WORLD NEWS SUPERFASTIndia News – From India-Mumbai to every small town-town in India, there is a fierce fight with Remedesvir. Somewhere politics is heating up, and somewhere people are buying it by paying many times more money in black. The central government said on Monday that Remedesvir Corona is not a life-saving drug for patients, it is unnecessary and its use will not benefit, it is not guaranteed. Seeing all this, on Monday, the Bombay High Court summoned the reply from the Central Government.The High Court questioned the Center on what basis these injections are being distributed to the states? When 40% of the corona patients in the country are in Maharashtra, Remedisvir should also be given in the same proportion. The High Court also reprimanded the Maharashtra government. The court said that the district is being distributed as arbitrary Remedisvir.Governments surrounded by Ramdesivir: Bombay HC asks Center – why not 40% of cases in Maharashtra so many injections?Earlier, the central government had banned the export of Remedicivir injection last week. Actually, this injection is being used in severe cases of corona. The doctors are also prescribing it indiscriminately and there is a lot of black marketing. At present, 7 companies in the country are making this drug, which has the capacity to make 39 lakh vials every month, ie 1.30 lakh doses daily. While the demand is constantly increasing.What is Ramesdivir?Remadecivir is an anti-viral drug, which reportedly stops the virus from growing. In 2009, Gilead Sciences of the US created it to treat Hepatitis C. Research was conducted on this till 2014 and then it was used in the treatment of Ebola. Remadecivir was then used in the treatment of Corona Virus Family’s Middle East Respiratory Syndrome (MERS or MERS) and Severe Acute Respiratory Syndrome (SARS or SARS).This formula overcomes the enzyme required for the virus to thrive in the body. On 28 October 2020, the US regulator US-FDA approved Remedisivir for the treatment of Kovid-19. When Donald Trump was infected at that time, he was also given Remedisvir.Is Remadecivir really effective?Do not know. According to data from Gilead Sciences Remadecivir Kovid-19 reduces the recovery time to five days. So far, more than 50 countries are using it in the treatment of Kovid-19. However, the WHO has not confirmed this claim in the trials.The WHO said that remadecivir has not shown any effect on the patient’s severe symptoms or life-threatening situations. Side effects have definitely been seen. These include increased levels of liver enzymes, allergic reaction, changes in blood pressure and heart rate, decreased levels of oxygen blood, fever, difficulty in breathing, swelling of lips, around eyes. Blood sugar is also shown to be enlarged.The Indian government has also said that this injection is not included in lifesaving medicineIt is not even given at home. Yet last week, the Center fixed the price of Remedicivir injection at Rs 3500. It also said that production would double by the end of April. For this, 6 more companies have been approved to produce it.Currently, 38.80 lakh injections are being produced every month in the country.About 8 million injections will be ready by the end of this month. According to the ministry, there are a total of 7 manufacturers of Remadecivir injection in the country at the moment. Now 6 more companies have been approved to produce it. With this, 10 lakh injections will be made every month. In addition, 3 million more units are in the final stages of construction.How many companies are making Remedisvir in India?There are 7 pharmaceutical companies in India currently manufacturing Remedisivir. These include Hetero Drugs, Zydus Cadila, Sun Pharma and Cipla. He has a licensing agreement with Gilead. These companies have a total production capacity of 39 lakh vials every month. Zydus reduced the price of 100 mg vial from Rs 2,800 to Rs 899 in March.
INDIA

By

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.